Brinker Harding Healthcare Corruption & Ethics Nebraska

Brinker Harding Says He'll 'Take On Big Pharma.' His Family Owns Up to $125,000 of Pfizer and AbbVie Stock.

Harding's campaign promises to take on Big Pharma and Big Insurance. His own financial disclosure shows six stakes in two of the world's biggest drugmakers — worth up to $125,000 — and his plan for drug prices is the same deal Pfizer signed and then raised prices anyway.

MAGA Report Cards · Sep 22, 2026

Brinker Harding Says He'll 'Take On Big Pharma.' His Family Owns Up to $125,000 of Pfizer and AbbVie Stock.

Brinker Harding, the Omaha city councilman running as the Republican for Nebraska's 2nd District, has made drug prices part of his pitch. His campaign website promises that in Congress he will "Take on Big Pharma and Big Insurance" so Americans "pay the same low prices for prescription drugs as other developed countries."

His own financial disclosure tells a different story about where his money is.

On June 12, 2026, Harding filed the personal financial disclosure that every House candidate has to submit. It lists six separate holdings in two of the largest drug companies in the world, American Journal News first reported:

AbbVie stock in his own retirement account — $1,001 to $15,000
Pfizer stock in his own retirement account — $1,001 to $15,000
AbbVie stock in his spouse's brokerage account — $1,001 to $15,000
Pfizer stock in his spouse's brokerage account — $1,001 to $15,000
AbbVie stock in his spouse's retirement account — $15,001 to $50,000
Pfizer stock in his spouse's retirement account — $1,001 to $15,000

House disclosures only require value ranges, not exact dollars. Add up the top of each range and the family's stake in the two drugmakers comes to as much as $125,000. The brokerage stakes alone paid his spouse between $201 and $1,000 each in dividends.

There is nothing illegal about owning drug stocks. The problem is the promise. A candidate who says he'll take on an industry — and whose household collects dividends from it — is asking voters to trust that he'll vote against his own family's portfolio.

The companies he'd be "taking on"

These aren't small players. Pfizer and AbbVie are two of the largest drug companies in the world. AbbVie makes the arthritis drug Humira.

Both have faced legal fights over what they charge. In 2023, Pfizer agreed to pay $50 million to settle antitrust claims from drug wholesalers over EpiPen. The same year, AbbVie faced a Dutch court case over whether Humira's price and its profits were too high.

His plan is the deal Pfizer already signed

Harding's fix for drug prices is "most favored nation" pricing — President Trump's plan to have the U.S. pay what other rich countries pay. On August 4, AJN reported, he posted a video endorsing it and saying "Nebraskans deserve affordable health care."

The problem is that Pfizer has already signed that deal. Pfizer was the first of 16 drug companies to announce a pricing agreement with the Trump administration, in September 2025. Then, NPR reported, it raised the prices of 72 products in January. NPR's headline said it plainly: "Trump struck deals with 16 drug companies. They're still raising prices."

The deals were also kept secret. When a watchdog group sued and pried two of them loose, Pfizer's turned out to let the company calculate its own prices for newly launched drugs. And while Trump bragged about cutting drug prices, the ten largest drugmakers took in $298 billion in six months.

So the "take on Big Pharma" plan Harding is selling is one the drug companies have already agreed to — and kept raising prices under. That's a plan his family's drug stocks can live with.

It's not the first time his paperwork caught up with his pitch

Harding also runs on cleaning up Congress and stopping lawmakers from cashing in. But as we reported in August, he went more than ten months without filing the very disclosure that lists these stocks — past the deadline, with no extension on record — and only filed after Nebraska Democrats referred him to the Justice Department. When he finally did, he said it proved he had "nothing to hide."

Now voters can see what was in it.

What the filings show

Brinker Harding promises to "Take on Big Pharma and Big Insurance." His own June 2026 disclosure lists six holdings in Pfizer and AbbVie across his and his spouse's accounts, worth as much as $125,000 combined. His plan for drug prices is the Trump "most favored nation" approach — the same kind of deal Pfizer signed in September 2025 before raising prices on 72 products in January.